Patent Portfolio Strategy

A patent portfolio strategy is a deliberate, business-aligned plan for acquiring, managing, and using patents to achieve specific objectives: WHY PORTFOLIOS MATTER MORE THAN INDIVIDUAL PATENTS: a single patent is fragile — it can be invalidated by IPR, designed around, or held unenforceable; a portfolio of patents covering multiple approaches, claim types, and embodiments creates overlapping protection that is harder to circumvent; WHAT THE STRATEGY MUST DO: (a) align IP investment with actual business priorities; (b) create barriers to entry that support the company's market position; (c) avoid wasting capital on patents that won't be enforced or licensed; (d) give the company freedom to operate in its core markets; KEY PORTFOLIO OBJECTIVES: OFFENSIVE: blocking competitors from making, using, or selling competing products; licensing to generate revenue; establishing licensing leverage in cross-licensing negotiations; DEFENSIVE: creating a patent stockpile to deter or counter-attack suits; freedom-to-operate insurance; FUNDRAISING/VALUATION: demonstrating IP assets to investors; CROSS-LICENSING: trading patents with technology partners to get access to their technology; WHAT A PORTFOLIO STRATEGY IS NOT: randomly filing patents on every invention without considering enforceability; accumulating low-value patents to inflate a patent count metric; filing applications primarily to delay publication of technology; COST REALITY: a single US patent costs $15,000-$50,000 from filing to issuance; maintaining it for 20 years adds $15,000+ in maintenance fees; multiplied across 100 patents and international filing = millions of dollars; strategy determines where that money is well spent.

Patent prioritization requires balancing invention significance, claim enforceability, and business value: TIER 1 — CORE TECHNOLOGY (FILE BROADLY): inventions that are central to the company's product or service; inventions without which the product does not work or loses significant competitive advantage; inventions the company expects to enforce or license; invest in multiple continuation applications, international filing, and broad claim sets; TIER 2 — IMPORTANT FEATURES (FILE SELECTIVELY): features that provide significant market differentiation; improvements to core technology that extend the first tier's protection; design around blockers — innovations designed specifically to cover design-arounds by competitors; file US applications; consider limited foreign filing in key markets; TIER 3 — DEFENSIVE DISCLOSURES (CONSIDER ALTERNATIVES): features that are important to the company but are unlikely to be commercially valuable as licensed patents; innovations you want to practice freely but do not wish to actively enforce; consider defensive publications in journals like IP.com or Google's Prior Art Archive — creates prior art blocking competitors from patenting, at zero cost vs. patent prosecution; PRIORITIZATION CRITERIA: is the technology likely to be copied by competitors?; is infringement detectable (you need to know if they infringe to enforce)?; is the market large enough to justify enforcement costs?; does the company have the resources to litigate if needed?; is the patent life long enough relative to the product lifecycle?; CLAIM-SCOPE PRIORITIZATION: within a given invention, prioritize applications with the broadest enforceable independent claims over those with narrow claims that are easy to design around.

Continuation practice is the primary tool for building portfolio depth and adapting claims to market conditions: CONTINUATION BASICS: a continuation application claims priority from a parent application; it must be filed while the parent is still pending; it uses the same specification; it can have entirely different claims; PORTFOLIO-BUILDING ROLE: a patent family based on one disclosure can include: (1) a parent with broad independent claims covering the core innovation; (2) continuation with claims directed to specific commercial embodiments; (3) continuation with method claims (to cover users, not just makers); (4) continuation with system claims; (5) continuation with narrower dependent claims that are harder to invalidate; (6) CIP (continuation-in-part) incorporating improvements; TIMING STRATEGY: file continuation applications before the parent issues (parent must still be pending); keep at least one continuation pending as long as possible — allows claiming emerging competitor products; when a competitor announces a new product, analyze whether a pending continuation can be prosecuted to cover it; CLAIM DRAFTING IN CONTINUATIONS: each continuation can be directed to a specific competitor or use case; claims can be drafted with knowledge of competitor products (obtained legitimately, e.g., from public announcements); 'prosecution laches' limits how long you can wait to file a continuation — unreasonable delay that prejudices an infringer can be a defense; PATENT FAMILY MAPPING: maintain a family tree showing parent-child relationships, allowed/pending status, and each application's claim focus; important for managing prosecution across the family; COST MANAGEMENT: don't file continuations just to fill a family tree; file only when there is a specific, valuable claim set to pursue.

Patent maintenance requires ongoing cost management — abandoning low-value patents is as important as filing high-value ones: MAINTENANCE FEE SCHEDULE (US PATENTS): 3.5-year maintenance fee: ~$2,000 (large entity); 7.5-year: ~$3,760; 11.5-year: ~$7,700; total maintenance for 20-year term: ~$13,460 (large entity) — small entity/micro entity pay 40-60% less; GLOBAL MAINTENANCE: international patents require annual annuity payments in each country; a single US patent in 10 countries costs $5,000-$15,000/year in annuities; PORTFOLIO PRUNING DECISIONS: annually review each patent for: (a) is the core technology still being used commercially?; (b) has the technology been superseded?; (c) are the claims broad enough to capture competitor conduct?; (d) is there a licensing target or enforcement opportunity?; (e) does maintaining the patent provide any competitive value?; PRUNING vs. KEEPING: a patent that costs $3,000/year to maintain but generates no licensing revenue, covers no currently-sold products, and is easy to design around should be abandoned; a patent that is part of an active licensing program or covers a core product feature should always be maintained; CLAIM REVIEW AT MAINTENANCE DECISION: if claims were allowed but are now considered too narrow, consider filing a continuation (if still pending application) before abandoning the parent; PORTFOLIO AUDITS: conduct comprehensive portfolio audits every 2-3 years; map each patent to current products and competitors; assess the strength of each patent's claims against known prior art; use the audit results to make pruning decisions and identify prosecution gaps.

International patent filing is one of the largest portfolio cost drivers and requires careful strategic analysis: PCT STRATEGY: the Patent Cooperation Treaty (PCT) allows filing a single international application covering 150+ countries within 12 months of the priority date; extends the deadline for entering national/regional phase to 30 months from priority date; COST STRUCTURE: PCT filing: $4,000-$6,000; at 30 months, national/regional phase entry (cost per country): US: $1,000+; EPO (Europe, covers 38+ countries): $8,000+; Japan: $4,000+; China: $3,000+; typical filing in US + EPO + JP + CN = $20,000+ just to enter national phase, plus ongoing prosecution and annuities; WHERE TO FILE — STRATEGIC CRITERIA: (a) where does the company sell products or has substantial sales?; (b) where do major competitors manufacture?; (c) where do major competitors sell?; (d) where are key licensees or potential licensees located?; (e) where does the company have sufficient resources to enforce the patent?; TYPICAL STARTUP APPROACH: prioritize US and select 2-4 markets (Europe, China/Japan/Korea for tech companies); Europe via EPO provides validation coverage efficiently; DEFENSIVE INTERNATIONAL FILING: some companies file in many countries purely for blocking — to prevent competitors from manufacturing in those jurisdictions; FREEDOM-TO-OPERATE INTERNATIONALLY: even if you have no international patents, you need FTO analysis in countries where you sell or manufacture; COST OPTIMIZATION: file PCT applications for all tier 1 inventions to preserve options; make national phase entry decisions at 28-30 months based on business development in each territory.